Paydirt
LN
Insider

Laura E Niklason

President, CEO and Director

Laura E Niklason (President, CEO and Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Humacyte, Inc. (HUMA). The largest single filing was $6.6M of HUMA (1,500,000 sh across 3 lots, as filed), executed Nov 18 2024.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.3M
shares × price, as filed
Last traded
Aug 20 2025
Filed Aug 20 2025

Median ADV $7.7M across their filed names

Open performance→
Volume by month
$6.6M$3.3M$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $6.6MAug 2025 · sells $3.7M
Buys $0 Sells $10.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 24 months

Most traded names
HUMA Humacyte, Inc. HUMA · 0 buys · 2 sells 2 filings
Recent filings
HUMASALE Humacyte, Inc. View filing → $3.7M
2,241,045 sh across 3 lots
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET HUMASALE Humacyte, Inc. View filing → $6.6M
1,500,000 sh across 3 lots
Exec Nov 18 2024
Filed Nov 20 2024 · 5:30 PM ET HUMASALE Humacyte, Inc. View filing → $2.4M
446,378 sh across 2 lots
Exec Sep 9 2024
Filed Sep 11 2024 · 5:30 PM ET